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Utrophin-Dystrophin-Deficient Mice
as a Model for Duchenne Muscular Dystrophy
Anne E. Deconinck,*§# Jill A. Rafael,*# disease is caused by lack of dystrophin, a large mem-
brane-associated protein expressed inmuscle and brainJudith A. Skinner,* Susan C. Brown,²
that is localized to the inner face of the cell membraneAllyson C. Potter,* Laurent Metzinger,*
(for review, see Tinsley et al., 1994; Blake et al., 1996).Diana J. Watt,³ J. George Dickson,²
The mdx mouse lacks dystrophin due to a mutation thatJonathon M. Tinsley,* and Kay E. Davies*‖
results in a premature stop codon in exon 23 (Bulfield*Genetics Unit
et al., 1984; Sicinski et al., 1989). Although this mouseDepartment of Biochemistry
has proved a valuable model for DMD, the progressiveUniversity of Oxford
muscle-wasting disease presents itself in a much milderSouth Parks Road
form than in humans, and the mice often live up to 2Oxford, OX1 3QU
years of age, which is comparable to the life span ofUnited Kingdom
wild-type mice (J. A. R., unpublished data). This differ-²School of Biological Sciences
ence might be attributable to the reduced life span ofRoyal Holloway
mice compared with humans, combined with a similarUniversity of London
rate of progression of the disease. Alternatively, com-Surrey, TW20 OEX
pensatory mechanisms present in mice may not haveUnited Kingdom
the same effects in humans, possibly due to an overall³Department of Anatomy
size difference and the overall force placed on theCharing Cross and Westminster Medical School
muscles.Fulham Palace Road
mdx muscle appears histologically normal in theLondon W6 8RF
immediate postnatal period, but an acute phase of mus-United Kingdom
cle necrosis occurs around weaning with visible muscle
weakness (Cullen and Jaros, 1988). Many cellular and
biochemical features resemble those characteristic of
Summary
the early myopathic phase of DMD, such as elevated
serum creatine kinase (CK) levels and accumulation of
The absence of dystrophin at the muscle membrane macrophages, which are indicative of muscle degenera-
leads to Duchenne muscular dystrophy (DMD), a se- tion. mdx skeletal muscle then recovers by virtue of
vere muscle-wasting disease that is inevitably fatal in substantial muscle regeneration morphologically char-
early adulthood. In contrast, dystrophin-deficient mdx acterized by small-caliber centrally nucleated fibers, and
mice appear physically normal despite their underly- mdx mice move and behave as normal mice. Upregu-
ing muscle pathology. We describe mice deficient for lated levels of muscle transcription factors appear to
both dystrophin and the dystrophin-related protein be integral components of this successful regeneration.
utrophin. These mice show many signs typical of DMD mdx mice lacking the muscle-specific transcription fac-
in humans: they show severe progressive muscular tor MyoD show a more severe dystrophy due to a defi-
dystrophy that results in premature death, they have ciency in regenerative capabilities of the muscle (Mege-
ultrastructural neuromuscular and myotendinous junc- ney et al., 1996). The ability of the mdx mouse to
tion abnormalities, and they aberrantly coexpress my- compensate for lack of dystrophin by increasing regen-
osin heavy chain isoforms within a fiber. The data erative activity is of interest not only in the investigation
suggest that utrophin and dystrophin have comple- of dystrophin function and DMD pathology but also in
menting roles in normal functional or developmental the search for potential therapeutic agents.
pathways in muscle. Detailed study of these mice Compensation for lack of dystrophin by structurally
should provide novel insights into the pathogenesis of related proteins such as utrophin may also be more
DMD and provide an improved model for rapid evalua- successful in the mouse, leading to a milder phenotype
tion of gene therapy strategies. than in humans. Utrophin localizes at the sarcolemma
of skeletal muscle fibers during fetal development; by
birth, dystrophin replaces utrophin at the sarcolemma.
Introduction Utrophin is now only present at neuromuscular and myo-
tendinous junctions (NMJ and MTJ) (Bewick et al., 1992;
Duchenne muscular dystrophy (DMD) is a common Law et al., 1994). However, high levels of utrophin are
(1/3300 boys), X-linked progressive muscle-wasting dis- present around the sarcolemma of regenerating myofi-
ease where patients are usually confined to a wheel bers in adult mdx skeletal muscle. Utrophin is also ex-
chair in their early teens and die by their early twenties pressed in heart, brain, and in nonmuscle tissues that
due to respiratory or cardiac failure (Emery, 1993). The lack full-length dystrophin (Helliwell et al., 1992; Karpati
et al., 1993; Pons et al., 1994a; Sewry et al., 1994). The
high amino acid identity between utrophin and dys-§Present address: Division of Hematology-Oncology, Childrens'
trophin in important functional domains suggests aHospital, Howard Hughes Medical Institute, Harvard Medical
possible redundancy between the two proteins. BothSchool, Boston, Massachusetts 02115.
proteins feature an N-terminal domain that binds to‖ To whom correspondence should be addressed.
# The first two authors contributed equally to this work. F-actin in the cytoskeleton (Winder et al., 1995) and a
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long rod domain of spectrin-like repeats. Utrophin also replacement of dystrophin. However, these transgenic
experiments do not indicate whether dystrophin andcontains a high degree of similarity to the cysteine-rich
and C-terminal regions of dystrophin that have been utrophin play complementary roles in normal muscle
function and development. Recent reports of utrophin-shown to interact with a set of transmembrane- and
membrane-associated proteins known as the dystro- null mutants indicate a structural role for utrophin in the
formation or stabilization of junctional folds during NMJphin-associated protein complex (DPC) (for review,
see Ozawa et al., 1995). The DPC consists of a- and maturation (Deconinck et al., 1997; Grady et al., 1997a).
However, these mice do not display any overt pheno-b-dystroglycan, a, b, g, d-sarcoglycan, and the syn-
trophins. b-dystroglycan has been shown to bind to the typic abnormalities or muscle weakness to date (12
months).cysteine-rich region of dystrophin in vitro and has been
proposed to be the direct link between dystrophin and To investigate the interrelationship between utrophin
and dystrophin in muscle, we interbred utrophin-nullthe DPC (Ozawa et al., 1995). Dystrophin is thought to
provide a link between the subsarcolemmal cytoskele- mice (utrn2/2) with mdx mice. Double-knockout (dko)
mice (mdx/utrn2/2) show many more of the clinical signston and the extracellular matrix through this protein
complex. Several autosomal recessive muscular dystro- of DMD than mdx mice, which show no phenotypic signs
of their underlying muscle pathology and live a normalphies are caused by mutations in the genes encoding
some of the DPC proteins (Campbell, 1995). life span. Dko mice show an earlier age of onset of
dystrophy in their diaphragm muscles, coexpression ofRecently, the expression of a utrophin minigene under
the control of a human a-skeletal actin promoter in myosin heavy chain (MHC) isoforms within skeletal mus-
cle fibers, and a marked alteration in junctional foldingmdx mice has been shown to restore the DPC to the
sarcolemma and to result in mice with greatly improved at the neuromuscular and myotendinous junctions. The
most obvious observation is that dko mice undergomuscle pathology (Tinsley et al., 1996). These data sug-
gest that the continued sarcolemmal presence of weight loss after weaning with the onset of joint con-
tractures and kyphosis, resulting in premature deathutrophin in skeletal muscle can lead to the functional
Figure 1. Utrophin/Dystrophin Deficiency
Leads to DMD-like Pathological Signs
In contrast with mdx mice (A, bottom), which
are physically indistinguishable from wild-
type mice, dko mutants are smaller in size (A,
top), with growth retardation starting around
weaning and eventual weight loss (E). The
mice are characterized by a slack posture (A),
a progressive curvature of the spine (kypho-
sis, B), and an abnormal waddling gait. Their
weight is carried on the hocks, which is pre-
sumably causing the waddling gait. The ab-
normal posture of the hind limbs and joint
contractures are also evident when the mice
are held by the tail (C) compared with normal
mice that reach out their back legs (D).
Utrophin-Deficient mdx Mice
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by 20 weeks of age. These observations suggest that
utrophin and dystrophin play synergistic roles in func-
tional or developmental pathways in skeletal muscle.
The testing of potential treatments for DMD in mice will
require not only an assessment of the improvement of
muscle pathology but an overall improvement in the
clinical features of the disease. Such an assessment
cannot be made in mdx mice, since their physical char-
acteristics appear outwardly normal. The utrophin/dys-
trophin-deficient mice presented here may provide a
more useful model for which to assess effective thera-
peutic strategies.
Results
Pathological Features of Mice Lacking
Dystrophin and Utrophin
To study the function of the dystrophin and utrophin
proteins and any redundancy between them, as well
as the significance of utrophin upregulation in the mdx
mouse, female mdx mice were mated to male utrophin
knockout mice. The F1 offspring were further interbred
following three different breeding schemes (described
in Experimental Procedures). Dko mice were identified
by ARMS assay PCR for dystrophin genotype (Amalfi- Figure 2. Dko Diaphragm Shows DMD-like Characteristics by Two
tano and Chamberlain, 1996) and Southern analysis or Weeks of Age
PCR for their utrophin genotype. The dko mutants were H&E-stained diaphragm section from a 2-week-old dko mouse
easily identifiable by 4 to 6 weeks of age by their slack shows the onset of a dystrophic pathology (top right). This pheno-
type contrasts the normal diaphragm morphology seen in mdx lit-posture and reduced weight (Figure 1A), lack of mo-
termate at the same age (top left). Immunohistochemistry with anbility, abnormal breathing pattern, and abnormal field
antibody raised against myosin heavy chain ªfastº isoform (MHC-f)behavior. These mice then showed progressive muscle
shows expression in almost all (.99%) fibers from a 2-week-oldweakness with marked kyphosis (profound, progressive
dko diaphragm (middle right). In contrast, only z90% of fibers in
dorsal-ventral curvature of the spine; Figure 1B), a char- an age-matched mdx diaphragm muscle express this isoform with
acteristic waddling gait with weight bearing on abnor- a characteristic scattered pattern of unstained fibers (middle left).
ªDevelopmentalº myosin heavy chain (MHC-dev) is not expressedmally postured hind limbs with joint contractures (Figure
in 2-day-old mdx diaphragm (bottom left) but is present in small1C) compared to mdx littermates (Figure 1D), and contin-
and large-caliber fibers in dko diaphragm muscles (bottom right).ued weight loss (Figure 1E). Mice that were given a
Bar 5 90 mm.mixture of powderedfood and water ina dishmaintained
their weight for a longer time; however, all mice suc-
cumbed to premature death by 20 weeks of age. show the characteristic morphological abnormalities
seen in mdx diaphragms (Figure 3A) with variation in
muscle fiber diameter and staining intensity, centralizedCharacterization of Skeletal Muscle
from Dko Mice nuclei, and fibrosis. Ultrastructural analysis of 10-week
dko diaphragmsfurther illustrates severe muscle degen-mdx mice do not show any muscle pathology until 3 to
4 weeks after birth, when the onset of necrosis is first eration and fibrosis (data not shown). Although there is
not as much connective tissue in dko diaphragms justseen in the diaphragm muscle. The timing of the age of
onset of muscular dystrophy in these mice has been prior to death as compared with diaphragms from 18-
month-old mdx mice (Figure 3C) as assessed by lighthypothesized to correspond to the disappearance of
utrophin from around thesarcolemma (Clerk et al., 1993). microscopy analysis, the lack of compensation by inter-
costal muscles may result in respiratory failure.To determine the age of onset of muscular dystrophy
in the dko mice, diaphragm muscles from 6-day-old Central nuclei are present in fibers that have regener-
ated, and the percentage of centrally nucleated fibersand 2-week-old dko mice were examined and compared
with diaphragm muscles from mdx littermates. Large is indicative of the amount of regeneration that has oc-
curred in a muscle. The percentage of centrally nucle-areas of necrotic fibers and connective tissue with little
evidence of regeneration were seen in the diaphragm ated fibers present in diaphragm muscles from 8-week-
old dko mice is 39.5%, compared with 38.3% presentof the 6-day-old dko but not in the age-matched mdx
littermates (data not shown). Diaphragm muscles from in diaphragm muscles from age-matched mdx controls
(Table 1A). These data suggest that the muscles from2-week-old dkos show these characteristics in addition
to large numbers of centrally nucleated fibers, demon- the dko mice possess the same history of regeneration
as seen in mdx mice.strating that muscle fiber regeneration is now occurring
(Figure 2, top). To assess sarcolemmal damage, diaphragm muscles
from five dko mice that were still fairly mobile, one withDiaphragm muscles from 8-week dkos (Figure 3B)
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Figure 3. Diaphragm Muscles from Age-
Matched mdx and Dko Mice Display a Similar
Pathology
H&E-stained unfixed frozen diaphragm sec-
tions from 18-week-old mdx (A) and dko (B)
mice show similar amounts of necrosis, fibro-
sis, and regeneration. Diaphragm muscles
from 8-month-old mdx mice (C) contain a
much higher proportion of collagen than do
dko mice, suggesting that the fibrosis of the
diaphragm muscle is not the primary cause
of death in dko mice. Uptake of reactive or-
ange by necrotic fibers in the diaphragmmus-
cles of mdx (D) and dko (E) mice appears
equivalent in the majority of sections ana-
lyzed. The diaphragm from a dko mouse that was assayed just prior to its natural death (F) shows a much higher proportion of necrotic fibers.
It is unknown whether this observation is a primary or secondary effect of the physical state of the animal just prior to analysis. Bar 5 62.5 mm.
severe weight loss and complete loss of mobility, and the minimal amounts of necrosis and fibrosis (data not
shown), and dko hearts did not appear to show anysix mdx controls, all at 10 weeks of age, were immersed
in a fluorescent, low molecular weight dye (reactive or- signs of a dilated cardiomyopathy. Overall, the skeletal
and cardiac muscle morphology of the dko mice is notange MW 631). This dye does not penetrate through
intact membranes but stains the cytoplasm of fibers drastically worse than that of mdx mice.
It is observed that mdx mice undergo fiber hypertro-with compromised membrane integrity. The diaphragm
muscles from the five moderately healthy dkos (Figure phy (Figure 4), presumably to increase muscle mass to
compensate for the loss of force-generating capacity3E) showed similar amounts of necrotic fibers to those
seen in the diaphragms of their mdx littermates (Figure due to dystrophin deficiency. To determine the capacity
for hypertrophy of dko limb muscles, the masses of TA,3D). The severely affected dko had a much higher pro-
portion of necrotic fibers (Figure 3F). It is unknown EDL, and soleus muscles from each leg of four 10-week-
old dko mice and four mdx littermates were determinedwhether this higher rate of necrosis was a cause or a
result of thephysical stateof this mouse. However, these
observations suggest overall that membrane integrity is
not different between dko and mdx mice.
Limb, axial, and heart muscles from adult littermates
of all four genotypes (wild type, mdx, utrn2/2, and dko)
were examined by H&E staining. Utrophin-deficient tibi-
alis anterior (TA) muscle appears morphologically nor-
mal (data not shown) until at least 1 year of age. In
mdx TA muscle, there are irregularly shaped and sized
muscle fibers, many with centralized nuclei and some
lymphocyte infiltration (Figure 4). The dko TA muscle
also shows extensive regeneration (central nuclei) and
the presence of macrophages (Figure 4). In gastrocne-
mius and quadriceps muscles of dko and mdx mice
(Figure 4), many eosinophilic and basophilic fibers are
present. Some fibers seem to contain fat or appear to
be replaced by adipose cells, as observed in advanced
DMD biopsies (Dubowitz, 1978). Similar results were
seen for extensor digitorum longus (EDL), soleus, and
paraspinal muscles (data not shown). Histologicalanaly-
sis of dko and mdx hearts shows similar variability in
Table 1. Quantitative Analysis of Dko versus mdx Muscle
A. Centrally Nucleated Fibers in the Diaphragm
mdx Dko
38.3% 39.5%
(n 5 1679) (n 5 2595)
B. Muscle Mass Relative to Total Body Mass Figure 4. Hindlimb Muscles from Dko and mdx Mice Show a Similar
Pathologymdx Dko
H&E-stained unfixed frozen sections of TA and quadriceps musclesTA .0053 .0045
and paraffin-embedded sections of gastrocnemius, from mdx andEDL .0010 .0012
dko littermates at z10 weeks of age, show variations in fiber size,Sol .00077 .00073
necrosis, fibrosis, and centrally nucleated fibers. Bar 5 120 mm.
Utrophin-Deficient mdx Mice
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Figure 5. Ultrastructural Analysis of NMJs and MTJs
Typical NMJ morphology in the diaphragm (A and B) and MTJ mor-
phology in the soleus muscle (C and D) of mdx (A and C) and dko
(B and D) mice at 10 weeks. The junctional folds seen in the mdx
Figure 6. Dp71 Is Overexpressed in Lung and Brain in the Absence(indicated by arrowheads) are notably absent in the dko mice. ax,
of Utrophinaxon; mf, muscle fiber; c, connective tissue; n, nucleus. Bar 5 5 mm.
Immunoblot of lung and brain total protein samples with a mono-
clonal antibody with specificity for the C terminus of dystrophin.
The C-terminal Dp71 isoform of dystrophin is expressed in these
and compared with the total body weights of the animals nonmuscle tissues and appears to be upregulated in utrn2/2 and
(Table 1B). No significant differences (p , 0.05) were dko samples.
detected between dko and mdx mice for any of these
three muscle types. These data suggest that the capac-
ity for hypertrophy seen in the mdx mouse is unaffected dko and mdx soleus revealed a marked reduction in
by the additional utrophin deficiency. However, it should membrane folding in the dko (Figure 5D) relative to the
be noted that body weights were significantly reduced mdx (Figure 5C), suggesting that force transmission may
in the dko mice compared with mdx littermates (see be impaired in dko skeletal muscle.
Figure 1E).
Compensation by Dystrophin C-Terminal Isoforms
Is Absent in Dko Skeletal MuscleUltrastructure of Neuromuscular and Myotendinous
Junctions in Dko Mice The strain of mdxmice used for interbreeding hasnormal
expression of the four shorter C-terminal dystrophin iso-To assess the morphology of the pre- and postsynaptic
regions of the NMJs in the absence of utrophin and forms (Dp71, Dp116, Dp140, and Dp260) (for review, see
Blake et al., 1996). The specificity of expression of thesedystrophin, diaphragm muscles from 10-week-old dko
and mdx littermates were examined by transmission different isoforms, as well as implication for involvement
in cognitive and ocular defects, suggests a defined roleelectron microscopy. At the NMJ in the diaphragm mus-
cles of dko mice at 10 weeks, the nerve terminals of the for these dystrophin isoforms (Blake et al., 1996). The
reduced neonatal survival rate due to poor maternalaxons appeared to be the same as those observed in
mdx muscle. However, an examination of the postsyn- care of another mdx strain, mdx3Cv, which lacks all of
the dystrophin locus transcripts, strengthens this sug-aptic motor endplate regions revealed a striking pheno-
typic abnormality with the virtual absence of folding at gestion (Cox et al., 1993). The absence of any aberrantly
expressed C-terminal dystrophin isoforms in mdx andthe postsynaptic membrane (Figure 5B). By contrast,
the majorityof mdxendplates displayed varyingdegrees dko skeletal muscle was confirmed by Western analysis
(data not shown). The fact that dko muscle, the onlyof postsynaptic folding (Figure 5A), although approxi-
mately one-third show a similar morphology to that dis- tissue where shorter transcripts are normally absent,
shows severe phenotypic abnormalities suggests thatplayed by dko mice. None of the endplates examined
were associated with obviously necrotic fibers. These these dystrophin C-terminal isoforms may be able to
compensate for the absence of full-length utrophin anddata suggest a role for utrophin and dystrophin in the
development or maintenance of junctional folds at the dystrophin in nonmuscle tissues. Consistent with this,
there is some indication that Dp71 levels are increasedpostsynaptic motor endplate.
The MTJs of normal mice are characterized by exten- in nonmuscle tissues such as lung and brain, both from
utrn2/2 and dko mutants (Figure 6).sive finger-like projections of the sarcolemmal mem-
brane. These folds serve to increase the surface area
for the attachment of the muscle fiber to the connective DPC Localization to the NMJs Is Not Dependent
on Dystrophin or Utrophintissue of the tendon and are thought toplay an important
role in the transmission of force between the muscle Immunohistochemistry on sectioned soleus or quadri-
ceps muscles from wild type, mdx, utrn2/2, and dko wasfiber and the tendon. A comparison of this region in the
Cell
722
performed using a panel of antibodies raised against least three subclasses (Schiaffino et al., 1989; Schiaffino
and Reggiani, 1994). Oxidative fibers normally expressDPC proteins. Sections were costained with a-bungaro-
toxin that binds to acetylcholine receptors (AChRs) and a different ªslowº isoform of MHC. The ratio of fast to
slow fibers differs between muscles and between spe-thereby labels NMJs. Antibodies raised against dys-
trophin-stained wild type and utrn2/2 sarcolemma, with cies, although a combination of the two basic classes
appears to beubiquitous (Yellin,1967; Joleszand Sreter,increased staining at the NMJ, presumably due to junc-
tional folds that increase the amount of membrane able 1981; Cho et al., 1993). Sections of diaphragm muscles
from 2-, 8-, and 10-week-old wild-type, mdx, utrn2/2,to accommodate dystrophin. Dystrophin was absent in
mdx and dko muscle, except for rare revertant fibers and dko mice were analyzed immunohistochemically
with antibodies specific for fast, slow, or developmental(data not shown). Utrophin was localized exclusively
to the NMJ in wild-type muscle, with additional weak MHC isoforms. Antibodies raised against the ªfastº MHC
isoform stained about 90% of fibers in diaphragm mus-sarcolemmal localization in mdx muscle, but was not
present in utrn2/2 or dko muscle (data not shown). cle from wild-type mice and a slightly higher percentage
of fibers in mdx diaphragm muscle. However, .99% ofTo assess the localization of members of the DPC,
antibodies specific for several members of the complex fibers in the diaphragms of the dko mice stained with
fast MHC, suggesting a difference in the proportion ofwere used to immunostain quadriceps muscle sections
from wild-type, mdx, and dko mice. Members of the oxidative muscle in these mice. Antibodies against the
developmental MHC isoform stained only small-caliber,DPC are greatly reduced at the sarcolemma of muscle
fibers of mdx mice compared with wild-type mice (Figure newly regenerated fibers in mdx diaphragm muscle.
However, large-caliber, noncentrally nucleated ªma-7). Immunostaining with antibodies raised against
b-dystroglycan (Figure 7) and a-sarcoglycan (data not tureº fibers in dko diaphragms were detected with this
antibody. This pattern of MHC isoform expression wasshown) on dko and mdx quadriceps muscle sections
shows similar localization at the NMJs and at low levels seen at least as early as 2 weeks of age (Figure 2).
Similar coexpression of MHC isoforms was also seenaround the sarcolemma (Figure 7). In Western analysis,
a reduction similar to that seen in mdx muscle was in soleus muscles (data not shown). Elevated levels of
the developmental MHC isoform in nonregenerating fi-observed in muscle from the dko mice, and no reduction
was observed in nonmuscle tissues (data not shown). bers and coexpression of developmental, slow, and/or
fast MHC isoforms in the same fibers suggest a roleImmunohistochemistry with antibodies raised against
b2-syntrophin shows that it is localized normally at the for utrophin and dystrophin in muscle development or
MHC-isoform expression.NMJs of dko mice (Figure 7).
In mdx heart, a- and g-sarcoglycan are only slightly
reduced. There appear to be increased levels of utrophin
Discussionin mdx heart, implying that utrophin may be responsible
for these relatively normal levels of DPC proteins (Pons
The data presented in this paper show that mice defi-et al., 1994b). However, Western analysis indicates that
cient in both dystrophin and utrophin show a severelevels of DPC proteins in dko heart are not reduced
progressive muscle-wasting disorder with early onsetwhen compared to mdx heart, again indicating that
and death within 20 weeks. These results demonstrateutrophin may not be an alternative binding partner (data
the synergy of these two proteins and also provide evi-not shown).
dence that the double mutant will be a valuable model
for the detailedstudy of the pathogenesis of DMD. Grady
Localization of Other Pre- and Postsynaptic et al. (1997b) show similar results (see accompanying
Proteins Is Unaffected in Dko Mice paper [this issue of Cell]).
The abundance of the AChR shows an z40% decrease DMD patients are gravely affected by absence of dys-
at the utrn2/2 NMJs as shown by a-bungarotoxin label- trophin, unlike the mdx mouse, which has no clinical
ing (Deconinck et al., 1997). Rapsyn, an NMJ-specific features and a relatively normal life span. It is possible
protein that colocalizes with AChRs and utrophin at the that the rate of progression of the myopathy due to the
crests of the synaptic folds, (Apel et al., 1995) is localized lack of dystrophin in mice and humans is similar and
normally in the dkos (Figure 7). The NMJ-specific marker that the two-year life span of a mouse is not long enough
acetylcholine esterase appears more scattered, which for the manifestation of the underlying muscle pathol-
may reflect not fully clustered AChRs and thus immature ogy. It is believed that mdx mice compensate for lack
muscle (data not shown). MuSK, a postsynaptic protein of dystrophin by increased muscle regeneration and
that serves as theagrin receptor,also retains its localiza- upregulation of otherproteins, such as muscle transcrip-
tion to the NMJs of thedko mice (data not shown) (Valen- tion factors, e.g., MyoD and structurally related proteins
zuela et al., 1995; DeChiara et al., 1996). The persistence such as utrophin (Matsumura et al., 1992). In view of
of AChRs, rapsyn, and MuSK indicates that utrophin the embryonic expression pattern of utrophin and its
is not required for the normal clustering of any of the exclusive localization at the NMJ and other cell±cell
members of the AChR complex. communication sites, utrn2/2 mice display a surprisingly
mild phenotype (Deconinck et al., 1997; Grady et al.,
1997a). The generation of a novel mouse mutant withCoexpression of Myosin Heavy Chain Isoforms
in Dko Skeletal Muscle a severe dystrophic phenotype, premature death, and
many cellular characteristics of DMD through the inter-In general, glycolytic myofibers express ªfastº isoforms
of MHC. Fast fibers can be further broken down into at breeding of mdx mice and utrn2/2 mice suggests that
Utrophin-Deficient mdx Mice
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Figure 7. Members of the Dystrophin-Associated and AChR Complexes Remain Localized at the NMJ in the Absence of Utrophin and
Dystrophin
Immunofluorescenceanalysis of C57 wild-type, mdx, and dko quadricepssections with antibodies raised against b-dystroglycan, b2-syntrophin,
and rapsyn show localization of all proteins at the NMJs in dko mice. Sections were costained with BODIPY-conjugated a-bungarotoxin (BT)
that binds to AChRs.
the mild phenotypes seen in the single mutants may be fiber size, connective tissue proliferation, extensive re-
generation (most fibers have central nuclei), replace-due to functional compensation between utrophin and
dystrophin. ment by adipose cells, presence of necrotic fibers, and
invasion by macrophages. The paraspinal and gastroc-The dko mice display marked myopathy, leading to
weight lossand breathing difficulties, resulting inprema- nemius muscles are themost severely affected muscles,
both in mdx and dko mouse mutants and in DMD pa-ture death. The primary cause of death of the dko mice
is most likely respiratory failure, but we are unable to tients. Many of the clinical features such as waddling
gait, arched spine, and premature death displayed byrule out contributions from such factors as cardiac com-
plications or the inability to eat and drink properly due the double mutants are similar to those described in
DMD patients. In contrast, mdx mice, which show ato weak tongue muscles. Histopathological analysis of
muscle sections shows many of the characteristic fea- more severe muscle pathology in older age than the
dkos do at the time of death, do not display these overttures also described in DMD biopsies and to a lesser
extent in the mdx mouse, including variation in muscle abnormalities at ages of at least one year.
Cell
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There are several mechanisms that may contribute to diaphragm must cause gross disruption in the spatial
organization of receptors and ion channels. Under thesethe phenotype of the dko mice. In view of the NMJ-
specific localization of utrophin, a defect in muscle in- conditions, defects in neuromuscular transmission might
be expected to be particularly deleterious, especially innervation may underlie some of the dystrophic symp-
toms. AChE appears slightly less clustered around some a muscle such as the diaphragm, which is subjected to
continual stimulation throughout life. However, minia-fibers in dko mice (data not shown), an initial indication
that there may be a developmental delay, as immature ture endplate potentials do not appear different from
those observed in utrn2/2 mice (T. Wang and A. Vincent,muscle is typified by unclustered synaptic proteins (Vin-
cent et al., 1997). However, our data suggest that post- personal communication). Therefore, the significance
of the reduction of the postsynaptic folding remainssynaptic proteins such as AChRs, rapsyn, and MuSK
are localized normally. unknown.
A reduction in folding at the MTJ has previously beenA reduction in the degree of folding at the postsynap-
tic membrane of the neuromuscular junction has pre- noted in mdx mice, although this defect appears to have
no detectable effects on the stress, strain, or energyviously been noted in both mdx (Torres and Duchen,
1987; Nagel et al., 1990; Lyons and Slater, 1991) and absorbed in this region. mdx muscle, if lengthened to
the point of rupture, fails at the same stress level asutrn2/2 mice (Deconinck et al., 1997; Grady et al., 1997a).
Moreover, approximately half of DMD endplates show identically loaded control muscle (Law et al., 1995).
However, the reduction in folding evident at the dkoultrastructural abnormalities consisting of focal degen-
eration of the postsynaptic junctional folds, simplifica- MTJ might be expected to increase markedly the forces
placed on individual contact areas between the fibertion of the postsynaptic region, and/or widening of the
synaptic cleft (Jerusalem et al., 1974). In normal muscle, membrane and connective tissue matrix thus leading to
membrane damage in this region. Since muscle growsdystrophin isconcentrated at the base of the postsynap-
tic folds, where there is a high density of voltage-gated by the addition of sarcomeres in this region, such de-
fects may also profoundly influence muscle growth.sodium channels (Flucher and Daniels, 1989; Sealock
et al., 1991; Bewick et al., 1992). However, its role in Since the levels of theDPC are greatly reduced around
the sarcolemma in the absence of dystrophin, andthis location with respect to the folds remains unclear,
as ultrastructural alterations at the mdx endplate are utrophin has been shown to be capable of interacting
with the DPC in utrophin/mdx transgenic mice (Tinsleythought to be a consequence of the effects of fiber
degeneration and regeneration rather than directly at- et al., 1996), we predicted that the members of the DPC
would be greatly reduced or completely absent at thetributable to the absence of dystrophin (Lyons and
Slater, 1991). Utrophin localizes to the crests of the post- NMJ in the absence of dystrophin and utrophin. How-
ever, all DPC proteins analyzed are retained at the NMJsynaptic folds, and its absence in utrn2/2 mice has been
shown to be associated with a reduction in postsynaptic in dko skeletal muscles. b-2 syntrophin, which is nor-
mally localized to the NMJ (Peters et al., 1994) andfolding and the number of AChRs (Deconinck et al.,
1997). Interestingly, the absence of both utrophin and was hypothesized to bind to the C-terminal region of
utrophin, is also localized normally in the absence ofdystrophin in dko mice fails to alter the general localiza-
tion of other NMJ-specific proteins such as rapsyn and dystrophin and utrophin. These data suggest that the
localization of these proteins at the NMJ is not depen-MuSK. However, the spatial organization and segrega-
tion of sodium channels and AChRs will be affected by dent upon interactions with utrophin, even though DPC
localization at the rest of the sarcolemma is dependentthe absence of folds at the postsynaptic cleft. These
observations taken together with those of mdx and upon interaction with dystrophin. Therefore, either there
is some inherent aspect of the membrane itself at theutrn2/2 mice tend to imply a role for utrophin and dys-
trophin in the development and/or stabilization of post- NMJ that is responsible for the maintenance of the DPC,
or there is an unspecified protein present at the NMJsynaptic folds that may be severely compromised either
directly by the absence of dystrophin at the base of the that is responsible for the stability of this protein com-
plex. These data suggest that dystrophin and utrophinfolds or indirectly by the successive rounds of muscle
fiber regeneration characteristic of dystrophin-deficient have other functions in addition to those involving the
DPC and have major implications regarding currentmuscle.
The functional consequences of postsynaptic fold models depicting the organization of the DPC complex
at the NMJ. However, the continued localization of thesereduction at the NMJ of the mdx mouse seem to be
minimal, since neither the miniature endplate potential proteins at the NMJ represents one more similarity be-
tween dko mice and DMD patients.frequency, quantal content of endplate potential, ampli-
tude, and time course of miniature endplate currents or The most dramatic cellular differences between mdx
and dko muscles are skewed ratios of fast-to-slow-the number of AChRs appear to be abnormal (Nagel et
al., 1990; Lyons and Slater, 1991). In utrn2/2 mice, a twitch muscle fibers and the preponderance of fibers
that coexpress multiple MHC isoforms. Developmentalreduction in the extent of postsynaptic folding leads to
a reduction in the number of AChRs but only minimal isoforms of MHC in large-caliber fibers are only ob-
served in dko muscle, suggesting a problem in muscleelectrophysiological alterations (Deconinck et al., 1997).
Thus, mdx and single-knockout utrn2/2 mice show only maturation. The lack of slow MHC or oxidative fibers in
the diaphragm muscle may account for the morbiditysubtle ultrastructural alterations at the endplate, and
neuromuscular transmission does not appear to be observed in the dko mice. The reliance on glycolytic
muscle fibers in the diaphragm for typical slow-twitchgreatly impaired. In the case of the dko mice, the almost
complete absence of postsynaptic folding in the dko activities such as breathing may tax the energy output
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(B) Female F1 (utrn1/2, mdx1/2) 3 male utrophin knockoutsmechanisms of the muscle and could lead to respiratory
(utrn2/2) produced F2s where 25% of the males were dkos.failure (Prakash et al., 1996). These observations of MHC
(C) Male F1 (utrn1/2, mdx) 3 female F1 (utrn1/2, mdx1/2) producedisoform expression correlate well with those seen in a
Mendelian ratios of utrophin and dystrophin. 12.5% of the progeny
study of nine DMD patients (Marini et al., 1991) and were dkos.
therefore define another similarity to DMD that is not
seen to a significant extent in mdx mice. Genotyping
DNA from tail biopsies was analyzed by ARMS assay PCR as pre-The data presented here illustrate that, in addition
viously describedto screen for the mdx allele (Amalfitano and Cham-to the previously described structural role at the NMJ
berlain, 1996). PCR analysis to determine utrophin-knockout status(Deconinck et al., 1997; Grady et al., 1997a), utrophin
used a forward primer complementary to exon 7 of mouse utrophin
may also have an important function in dystrophin-defi- (59 GTG AAG GAT GTC ATG AAA G 39) and reverse primers comple-
cient muscle. Such a proposal does not appear to be mentary to either intron 7 (59 TGA AGT CCG AAA GAG ATA CC 39)
consistent with the mild phenotype described for utrn2/2 or to the PGK promoter located within the Neo-knockout cassette
(59 ACG AGA CTA GTG AGA CGT GC 39). Reactions were carriedmice. However, the lack of myopathy in the utrophin-
out on genomic DNA for 35 cycles under the following conditions:knockout mice may be the result of the continued local-
948C, 30 s; 578C, 30 s; 728C, 25 s.ization of dystrophin at the NMJ, possibly stabilizing the
utrophin-deficient junctional folds. A consideration of Histological Analysis
the phenotypes of each single-knockout mouse com- Mice were sacrificed and tissues excised, embedded in Cryo-M-
pared with the phenotype of mice deficient for both Bed (Bright, Huntingdon, Cambs, England), frozen in liquid nitrogen-
cooled isopentane. Frozen sections (8 mm) of these quadriceps,utrophin and dystrophin suggests that these two pro-
soleus, and diaphragm samples were cut on a cryostat. TA andteins play roles in complementing developmental or
gastrocnemius samples were fixed in paraformaldehyde and em-functional pathways. The loss of both proteins results
bedded in paraffin. All sections were stained with hematoxylin andin far greater consequences than simply the combina- eosin (H&E) as standard.
tion of the two independent phenotypes. Overexpres-
sion of either protein may fully compensate for the loss Western Analysis
of the other, as suggested by the recent report describ- Tissues were homogenized in gel loading buffer (75 mM Tris-HCl
[pH 6.8], 3.8% SDS, 4 M urea, and 20% glycerol) and the total proteining the prevention of the dystrophic phenotype of mdx
content assessed (Bio-Rad DC Assay kit). Following addition of 5%mice with a utrophin transgene (Tinsley et al., 1996).
b-mercaptoethanol and 0.001% bromophenol blue, 100 mg of eachFurther analysis is being carried out to investigate the
extract was separated on an SDS-polyacrylamide gel (8% for dys-
function of utrophin in cardiac muscle and other tissues trophin and utrophin; 12% for b-dystroglycan) and electroblotted
where utrophin is highly expressed. Although we do not onto a nitrocellulose membrane. The membranes were then incu-
observe any dilated cardiomyopathies in these mice, bated with antibodies to utrophin (MANCHO7), or dystrophin
(MANDYS1 and MANDRA1, all used at 1/100; kind gifts of Dr. G. E.there could certainly be milder cardiac abnormalities for
Morris). Bound primary antibodies were detected by horseradishwhich we cannot account. The relative contributions of
peroxidase-conjugated secondary antibodies followed by chemilu-each type of striated muscle to the primary cause of
minescence (Boehringer).
death in these mice must await the generation of dko
mice expressing utrophin transgenes in a variety of pat- Immunofluorescence Analysis
terns in limb muscles, diaphragm, and heart. All immunolabeling was done on 8 mm thick unfixed sections of
muscle frozen in isopentane cooled in liquid nitrogen. Sections wereFinally, a variable neurogenic component may exist
preincubated with 1% gelatin in potassium-phosphate-buffered sa-in the pathology of DMD, particularly in relation to peri-
line (KPBS) for 30 min at room temperature. Antibodies were appliedods of ongoing degeneration. In addition, dystrophin
in KPBS plus 0.2% gelatin plus 1% normal goat serum for 2 hr at
and utrophin are components of the postsynaptic appa- room temperature. Primary antibodies against the followingproteins
ratus in many CNS neurons, particularly the cerebral were used: utrophin, dystrophin (G3 [1/25] and P6 [1/800], polyclon-
cortex. The dko mice may thus serve as a model not als, kind gift of Dr. C. A. Sewry, London, UK), b-dystroglycan,
a-sarcoglycan (polyclonals, kind gift of Dr. K. P. Campbell, Iowa),only to study potential therapies for DMD and the basic
rapsyn, laminin (polyclonals raised by Dr. A. Vincent against recom-cell biology of the NMJ but also to provide clear insights
binant proteins, kindly provided by Dr. J. R. Sanes, St. Louis), MuSKinto subtle neurogenic components in the pathology of
(polyclonal, used at 1/100, kind gift of Dr. S. Burden), fast and slow
the muscular dystrophies as a whole. MHC isoforms (mouse monoclonals, Novacostra, Newcastle-upon-
Tyne, UK), and developmental myosin (mouse monoclonal, kind gift
of L. V. B. Anderson).Experimental Procedures
Immunoreactivity was visualized using secondary antibodies con-
jugated with FITC (Sigma). Sections were costained with BODIPY-Breeding Schemes
a-BgTx (0.6 3 1026 M, Molecular Probes) to identify NMJs. LabeledMice deficient in both dystrophin and utrophin (double knockouts)
sections were mounted in Vectashield (Vector Laboratories) andwere derived by a breeding program as follows: female C57Bl/10
viewed using a Leica DMRBE microscope. Sections incubated inmdx mice (deficient in dystrophin) were mated with male utrophin-
dilutent without primary antibody served as controls for nonspecificnull mice (utrn2/2) (Deconinck et al., 1997), resulting in an F1 genera-
binding of secondary antibodies.tion heterozygous for utrophin and either heterozygous for the mdx
mutation (females) or hemizygous for the mdx mutation (males). This
F1 generation was used to produce dko mice in three ways: Reactive Orange
Complete diaphragm muscles from mdx and dko mice were re-(A) Male F1 (utrn1/2, mdx) 3 female mdx (utrn1/1, mdx/mdx) gave
an F2 generation all mdx and either wild type or heterozygous at moved and soaked for 1 hr in 0.2% reactive orange (Sigma) in F10
tissue culture media (Sigma). Diaphragms were then rinsed brieflythe utrophin locus. Male and female F2 mice heterozygous for the
utrophin knockout were mated and the progeny were all mdx, of in F10 media, cut into pieces, embedded in Cryo-M-Bed (Bright,
Huntingdon, Cambs, England), and frozen in liquid nitrogen-cooledwhich 25% were utrn2/2 (dkos). utrn1/1, mdx/mdx littermates re-
sulting from this mating scheme were used as mdx control lit- isopentane. Sections (8 mm) were cut on a cryostat and visualized
through an FITC filter using a Leica DMRBE microscope.termates in all dko analyses.
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Ultrastructural Analysis Flucher, B.E., and Daniels, M.P. (1989). Distribution of Na1 channels
and ankyrin in neuromuscular junctions is complementary to that ofExcised muscles were fixed in 3% glutaraldehyde and 4% formalde-
hyde in 0.1 M PIPES buffer at pH 7.2 for 1 hr, postfixed in 1% osmium acetylcholine receptors and the 43 kDa protein. Neuron 3, 163±175.
0.1 M PIPES for 1 hr, and embedded in TAAB (TAAB Laboratories, Grady, R.M., Merlie, J.P., and Sanes, J.R. (1997a). Subtle neuromus-
Aldermaston, UK) resin. Gold/Silver (90 nm) sections were cut using cular defects in utrophin-deficient mice. J. Cell Biol. 136, 871±882.
a Cambridge Huxley MKII Ultramicrotome, stained with alcoholic Grady, R.M., Teng, H., Nichol, M.C., Cunningham, J.C., Wilkinson,
uranyl acetate and lead stain, and viewed using a Zeiss EM109. R.S., and Sanes, J.R. (1997b). Skeletal and cardiac myopathies in
mice lacking utrophin and dystrophin: a model for Duchenne muscu-
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